Clovis Oncology
CLVS
#10063
Rank
S$15.83 M
Marketcap
$0.11
Share price
0.00%
Change (1 day)
-95.09%
Change (1 year)

P/S ratio for Clovis Oncology (CLVS)

P/S ratio on February 22, 2023 (TTM) : 0.0885

According to Clovis Oncology's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.0282. At the end of 2022 the company had a P/S ratio of 1.29.

P/S ratio history for Clovis Oncology from 2011 to 2022

PS ratio at the end of each year

Year P/S ratio Change
20221.29-45.05%
20212.35-22.26%
20203.03-24.48%
20194.01-59.7%
20189.94-83.88%
201761.7-99.72%
2016> 1000
2015N/A-100%
2014140
2013N/A
2012N/A
2011N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.14 4,582.39%๐Ÿ‡บ๐Ÿ‡ธ USA
3.97 4,386.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
2.07 2,241.48%๐Ÿ‡บ๐Ÿ‡ธ USA
4.20 4,647.45%๐Ÿ‡บ๐Ÿ‡ธ USA
6.03 6,717.28%๐Ÿ‡บ๐Ÿ‡ธ USA
14.9 16,766.27%๐Ÿ‡บ๐Ÿ‡ธ USA